CompletedNot applicableNCT06183801

Effects of Probiotics on Metabolic Syndrome ,Intestinal Microflora and SCFA.

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Glac Biotech Co., Ltd
Principal Investigator
Hsieh-Hsun Ho, Ph. D.
Study Principal Investigator
Intervention
Probiotics 1(dietary_supplement)
Enrollment
82 enrolled
Eligibility
All sexes
Timeline
20212023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06183801 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials